Search

Your search keyword '"Herrera, Concepción"' showing total 212 results

Search Constraints

Start Over You searched for: Author "Herrera, Concepción" Remove constraint Author: "Herrera, Concepción"
Sorry, I don't understand your search. ×
212 results on '"Herrera, Concepción"'

Search Results

1. Mesenchymal stromal cell therapy for COVID-19 acute respiratory distress syndrome: a double-blind randomised controlled trial

Catalog

Books, media, physical & digital resources

3. Heterogeneization of Biodiesel Production by Simultaneous Esterification and Transesterification of Oleins.

7. Haploidentical Transplantation with Post-Transplantation Cyclophosphamide for T Cell Acute Lymphoblastic Leukemia: A Report from the European Society for Blood and Marrow Transplantation Acute Leukemia Working Party

8. Evaluation of convalescent plasma versus standard of care for the treatment of COVID-19 in hospitalized patients: study protocol for a phase 2 randomized, open-label, controlled, multicenter trial

9. Double-blind, randomized, controlled, trial to assess the efficacy of allogenic mesenchymal stromal cells in patients with acute respiratory distress syndrome due to COVID-19 (COVID-AT): A structured summary of a study protocol for a randomised controlled trial

10. Thrombopoietin Receptor Agonists for Severe Thrombocytopenia after Allogeneic Stem Cell Transplantation: Experience of the Spanish Group of Hematopoietic Stem Cell Transplant

15. Outcomes of Unmanipulated Haploidentical Transplantation Using Post-Transplant Cyclophosphamide (PT-Cy) in Pediatric Patients With Acute Lymphoblastic Leukemia

16. Mesenchymal stromal cell therapy for COVID-19 acute respiratory distress syndrome: A double-blind randomised controlled trial

19. Longer intervals between SARS‐CoV‐2 infection and mRNA‐1273 doses improve the neutralization of different variants of concern

22. Functional Improvement in Patients With Dilated Cardiomyopathy After the Intracoronary Infusion of Autologous Bone Marrow Mononuclear Cells

23. Mejoría funcional en pacientes con miocardiopatía dilatada tras la infusión intracoronaria de células mononucleares autólogas de la médula ósea

24. Bi‐Reforming of Biogas for Hydrogen Production with Sulfur‐Resistant Multimetallic Catalyst.

28. Comparison of Cu-CHA-Zeolites in the Hybrid NSR-SCR Catalytic System for NO x Abatement in Mobile Sources.

30. Functional Recovery Following Intracoronary Infusion of Autologous Mononuclear Bone Marrow Cells in Patients With Chronic Anterior Myocardial Infarction and Severely Depressed Ventricular Function

31. Recuperación funcional tras infusión intracoronaria de células mononucleadas de médula ósea autóloga en pacientes con infarto crónico anterior y depresión severa de la función ventricular

33. SISTEMAS CATALÍTICOS HÍBRIDOS PARA LA REDUCCIÓN DE CONTAMINANTES EN MOTORIZACIÓN DIÉSEL

34. Nurses competence in the reporting of medication‐related incidents: An intervention study.

35. Use of non-specific intravenous human immunoglobulins in Spanish hospitals; need for a hospital protocol

36. Additional file 1 of Evaluation of convalescent plasma versus standard of care for the treatment of COVID-19 in hospitalized patients: study protocol for a phase 2 randomized, open-label, controlled, multicenter trial

37. Additional file 2 of Evaluation of convalescent plasma versus standard of care for the treatment of COVID-19 in hospitalized patients: study protocol for a phase 2 randomized, open-label, controlled, multicenter trial

40. Isotopic study of the influence of oxygen interaction and surface species over different catalysts on the soot removal mechanism

44. Evaluation of Convalescent Plasma Versus Standard of Care for the Treatment of COVID-19 in Hospitalized Patients: study protocol for a phase 2 randomized, open-label, controlled, multicenter trial

45. A Retrospective Controlled Cohort Study of the Impact of Glucocorticoid Treatment in SARS-CoV-2 Infection Mortality

46. IMPACT OF GLUCOCORTICOID TREATMENT IN SARS-COV-2 INFECTION MORTALITY: A RETROSPECTIVE CONTROLLED COHORT STUDY

50. MEsenchymal StEm cells for Multiple Sclerosis (MESEMS): a randomized, double blind, cross-over phase I/II clinical trial with autologous mesenchymal stem cells for the therapy of multiple sclerosis